Literature DB >> 10588754

Opposite effects of nitric oxide and nitroxyl on postischemic myocardial injury.

X L Ma1, F Gao, G L Liu, B L Lopez, T A Christopher, J M Fukuto, D A Wink, M Feelisch.   

Abstract

Recent experimental evidence suggests that reactive nitrogen oxide species can contribute significantly to postischemic myocardial injury. The aim of the present study was to evaluate the role of two reactive nitrogen oxide species, nitroxyl (NO(-)) and nitric oxide (NO(.)), in myocardial ischemia and reperfusion injury. Rabbits were subjected to 45 min of regional myocardial ischemia followed by 180 min of reperfusion. Vehicle (0.9% NaCl), 1 micromol/kg S-nitrosoglutathione (GSNO) (an NO(.) donor), or 3 micromol/kg Angeli's salt (AS) (a source of NO(-)) were given i.v. 5 min before reperfusion. Treatment with GSNO markedly attenuated reperfusion injury, as evidenced by improved cardiac function, decreased plasma creatine kinase activity, reduced necrotic size, and decreased myocardial myeloperoxidase activity. In contrast, the administration of AS at a hemodynamically equieffective dose not only failed to attenuate but, rather, aggravated reperfusion injury, indicated by an increased left ventricular end diastolic pressure, myocardial creatine kinase release and necrotic size. Decomposed AS was without effect. Co-administration of AS with ferricyanide, a one-electron oxidant that converts NO(-) to NO(.), completely blocked the injurious effects of AS and exerted significant cardioprotective effects similar to those of GSNO. These results demonstrate that, although NO(.) is protective, NO(-) increases the tissue damage that occurs during ischemia/reperfusion and suggest that formation of nitroxyl may contribute to postischemic myocardial injury.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10588754      PMCID: PMC24485          DOI: 10.1073/pnas.96.25.14617

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Induction of DNA strand breakage and base oxidation by nitroxyl anion through hydroxyl radical production.

Authors:  H Ohshima; I Gilibert; F Bianchini
Journal:  Free Radic Biol Med       Date:  1999-05       Impact factor: 7.376

2.  Cardioprotection and attenuation of endothelial dysfunction by organic nitric oxide donors in myocardial ischemia-reperfusion.

Authors:  M R Siegfried; J Erhardt; T Rider; X L Ma; A M Lefer
Journal:  J Pharmacol Exp Ther       Date:  1992-02       Impact factor: 4.030

3.  Intracellular but not extracellular conversion of nitroxyl anion into nitric oxide leads to stimulation of human neutrophil migration.

Authors:  B E Vanuffelen; J Van Der Zee; B M De Koster; J Vansteveninck; J G Elferink
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

4.  Direct measurement of free radical generation following reperfusion of ischemic myocardium.

Authors:  J L Zweier; J T Flaherty; M L Weisfeldt
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

5.  Myocardial ischemia-reperfusion injury is exacerbated in absence of endothelial cell nitric oxide synthase.

Authors:  S P Jones; W G Girod; A J Palazzo; D N Granger; M B Grisham; D Jourd'Heuil; P L Huang; D J Lefer
Journal:  Am J Physiol       Date:  1999-05

6.  Effect of superoxide dismutase on the stability of S-nitrosothiols.

Authors:  D Jourd'heuil; F S Laroux; A M Miles; D A Wink; M B Grisham
Journal:  Arch Biochem Biophys       Date:  1999-01-15       Impact factor: 4.013

7.  SP/W-5186, A cysteine-containing nitric oxide donor, attenuates postischemic myocardial injury.

Authors:  G L Liu; T A Christopher; B L Lopez; F Gao; Y Guo; E Gao; K Knuettel; M Feelisch; X L Ma
Journal:  J Pharmacol Exp Ther       Date:  1998-11       Impact factor: 4.030

8.  Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium.

Authors:  K M Mullane; R Kraemer; B Smith
Journal:  J Pharmacol Methods       Date:  1985-11

9.  Paradoxical fate and biological action of peroxynitrite on human platelets.

Authors:  M A Moro; V M Darley-Usmar; D A Goodwin; N G Read; R Zamora-Pino; M Feelisch; M W Radomski; S Moncada
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-05       Impact factor: 11.205

10.  Formation of free nitric oxide from l-arginine by nitric oxide synthase: direct enhancement of generation by superoxide dismutase.

Authors:  A J Hobbs; J M Fukuto; L J Ignarro
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

View more
  47 in total

1.  Positive inotropic and lusitropic effects of HNO/NO- in failing hearts: independence from beta-adrenergic signaling.

Authors:  Nazareno Paolocci; Tatsuo Katori; Hunter C Champion; Marcus E St John; Katrina M Miranda; Jon M Fukuto; David A Wink; David A Kass
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-18       Impact factor: 11.205

Review 2.  NO and the vasculature: where does it come from and what does it do?

Authors:  Karen L Andrews; Chris R Triggle; Anthie Ellis
Journal:  Heart Fail Rev       Date:  2002-10       Impact factor: 4.214

3.  Mechanisms of the interaction of nitroxyl with mitochondria.

Authors:  Sruti Shiva; Jack H Crawford; Anup Ramachandran; Erin K Ceaser; Tess Hillson; Paul S Brookes; Rakesh P Patel; Victor M Darley-Usmar
Journal:  Biochem J       Date:  2004-04-15       Impact factor: 3.857

Review 4.  The pharmacology of nitroxyl (HNO) and its therapeutic potential: not just the Janus face of NO.

Authors:  Nazareno Paolocci; Matthew I Jackson; Brenda E Lopez; Katrina Miranda; Carlo G Tocchetti; David A Wink; Adrian J Hobbs; Jon M Fukuto
Journal:  Pharmacol Ther       Date:  2006-11-29       Impact factor: 12.310

Review 5.  The emergence of nitroxyl (HNO) as a pharmacological agent.

Authors:  Christopher H Switzer; Wilmarie Flores-Santana; Daniele Mancardi; Sonia Donzelli; Debashree Basudhar; Lisa A Ridnour; Katrina M Miranda; Jon M Fukuto; Nazareno Paolocci; David A Wink
Journal:  Biochim Biophys Acta       Date:  2009-05-06

6.  Direct detection of nitroxyl in aqueous solution using a tripodal copper(II) BODIPY complex.

Authors:  Joel Rosenthal; Stephen J Lippard
Journal:  J Am Chem Soc       Date:  2010-04-28       Impact factor: 15.419

7.  Angeli's salt counteracts the vasoactive effects of elevated plasma hemoglobin.

Authors:  Steven B Solomon; Landon Bellavia; Daniel Sweeney; Barbora Piknova; Andreas Perlegas; Christine C Helms; Gabriela A Ferreyra; S Bruce King; Nicolaas J H Raat; Steven J Kern; Junfeng Sun; Linda C McPhail; Alan N Schechter; Charles Natanson; Mark T Gladwin; Daniel B Kim-Shapiro
Journal:  Free Radic Biol Med       Date:  2012-10-23       Impact factor: 7.376

8.  The reduction potential of nitric oxide (NO) and its importance to NO biochemistry.

Authors:  Michael D Bartberger; Wei Liu; Eleonora Ford; Katrina M Miranda; Christopher Switzer; Jon M Fukuto; Patrick J Farmer; David A Wink; Kendall N Houk
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-12       Impact factor: 11.205

Review 9.  Therapeutic Potential of Nitroxyl (HNO) Donors in the Management of Acute Decompensated Heart Failure.

Authors:  Barbara K Kemp-Harper; John D Horowitz; Rebecca H Ritchie
Journal:  Drugs       Date:  2016-09       Impact factor: 9.546

10.  A biochemical rationale for the discrete behavior of nitroxyl and nitric oxide in the cardiovascular system.

Authors:  Katrina M Miranda; Nazareno Paolocci; Tatsuo Katori; Douglas D Thomas; Eleonora Ford; Michael D Bartberger; Michael G Espey; David A Kass; Martin Feelisch; Jon M Fukuto; David A Wink
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.